The Surgical Hemostats Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Surgical Hemostats Global Market has seen significant growth recently. It is expected to expand from $3.68 billion in 2024 to $3.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
The Surgical Hemostats Global Market is predicted to reach a value of $5.09 billion in 2029, expanding at a compound annual growth rate (CAGR) of 6.6%.
Download Your Free Sample of the 2025 Surgical Hemostats Market Report and Uncover Key Trends Now!The key drivers in the surgical hemostats market are:
• Increase in trauma cases globally
• Rising occurrence of road traffic accidents
• High demand for quick and effective bleeding control tools in trauma cases
• Growing need for surgical hemostats in urgent medical interventions.
The surgical hemostats market covered in this report is segmented –
1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
The key trends in the surgical hemostats market are:
• The increasing focus on the development of advanced products utilizing innovative materials like absorbable oxidized regenerated cellulose is seen as a major trend.
• The application of such materials in surgical hemostats to enhance bleeding control and promote faster wound healing is witnessing expanding adoption.
• Rapid hemostasis products that are fully absorbable, eliminating the need for removal are emerging as a significant trend.
• The growing production of non-toxic, biocompatible surgical hemostats with antibacterial properties is an emerging direction in the market.
Major players in the surgical hemostats market are:
• Johnson And Johnson Services Inc.
• Medtronic plc
• Becton Dickinson And Company
• Stryker Corporation
• Baxter International Inc.
• Teleflex Corporation
• Integra LifeSciences Holdings Corporation
• GELITA MEDICAL GmbH
• B. Braun Melsungen AG
• Advanced Medical Solutions Group plc
• Axio Biosolutions Pvt. Ltd.
• Marine Polymer Technologies Inc
• Biom'up USA Inc
• Lotus Surgicals Pvt. Ltd
• Hemostasis LLC
• Biocer Entwicklungs-GmbH
• CuraMedical BV
• EndoClot Plus Inc
• Starch Medical Inc
• Tricol Biomedical Inc
North America was the largest region in the surgical hemostats market in 2024